Evidence map›Paper›PMID 38692714›Full record

ArticleBMJ open2024

Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional study.

Marco Vincenzo Lenti, Alessia Ballesio, Gabriele Croce, Alice Silvia Brera, Lucia Padovini, Giampiera Bertolino, Antonio Di Sabatino, Catherine Klersy, Gino Roberto Corazza

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Marco Vincenzo LentiDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.ORCID 0000-0002-6654-4911
Alessia BallesioDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Gabriele CroceDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Alice Silvia BreraDepartment of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Lucia PadoviniDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Giampiera BertolinoDepartment of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Antonio Di SabatinoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Catherine KlersyService of Clinical Epidemiology & Biometry, Research Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID 0000-0003-0314-8548
Gino Roberto CorazzaDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy gr.corazza@smatteo.pv.it.ORCID 0000-0001-9532-0573
University of Pavia · ITPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere are no data regarding the prevalence of comorbidity (ie, additional conditions in reference to an index disease) and multimorbidity (ie, co-occurrence of multiple diseases in which no one holds priority) in patients with liver cirrhosis. We sought to determine the rate and differences between comorbidity and multimorbidity depending on the aetiology of cirrhosis.

designThis is a subanalysis of the San MAtteo Complexity (SMAC) study. We have analysed demographic, clinical characteristics and rate of comorbidity/multimorbidity of patients with liver cirrhosis depending on the aetiology-alcoholic, infectious and non-alcoholic fatty liver disease (NAFLD). A multivariable analysis for factors associated with multimorbidity was fitted.

settingSingle-centre, cross-sectional study conducted in a tertiary referral, academic, internal medicine ward in northern Italy (November 2017-November 2019).

participantsData from 1433 patients previously enrolled in the SMAC study were assessed; only those with liver cirrhosis were eventually included.

resultsOf the 1433 patients, 172 (median age 79 years, IQR 67-84; 83 females) had liver cirrhosis. Patients with cirrhosis displayed higher median Cumulative Illness Rating Scale (CIRS) comorbidity (4, IQR 3-5; p=0.01) and severity (1.85, IQR 16.-2.0; p<0.001) indexes and lower educational level (103, 59.9%; p=0.003). Patients with alcohol cirrhosis were significantly younger (median 65 years, IQR 56-79) than patients with cirrhosis of other aetiologies (p<0.001) and more commonly males (25, 75.8%). Comorbidity was more prevalent in patients with alcohol cirrhosis (13, 39.4%) and multimorbidity was more prevalent in viral (64, 81.0%) and NAFLD (52, 86.7%) cirrhosis (p=0.015). In a multivariable model for factors associated with multimorbidity, a CIRS comorbidity index >3 (OR 2.81, 95% CI 1.14 to 6.93, p=0.024) and admission related to cirrhosis (OR 0.19, 95% CI 0.07 to 0.54, p=0.002) were the only significant associations.

conclusionsComorbidity is more common in alcohol cirrhosis compared with other aetiologies in a hospital, internal medicine setting.

Indexed as

ComorbidityInternal MedicineLiver CirrhosisMultimorbidityAgedAged, 80 and overCross-Sectional StudiesFemaleHospitalizationHumansItalyMaleMiddle AgedNon-alcoholic Fatty Liver DiseasePrevalenceAdult gastroenterologyAgingHepatobiliary disease

Identifiers

PMID38692714
PMCPMC11086508
OpenAlexW4396544698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.